Unknown

Dataset Information

0

In Situ Immune Profiling of Heart Transplant Biopsies Improves Diagnostic Accuracy and Rejection Risk Stratification.


ABSTRACT: Recognizing that guideline-directed histologic grading of endomyocardial biopsy tissue samples for rejection surveillance has limited diagnostic accuracy, quantitative, in situ characterization was performed of several important immune cell types in a retrospective cohort of clinical endomyocardial tissue samples. Differences between cases were identified and were grouped by histologic grade versus clinical rejection trajectory, with significantly increased programmed death ligand 1+, forkhead box P3+, and cluster of differentiation 68+ cells suppressed in clinically evident rejections, especially cases with marked clinical-histologic discordance. Programmed death ligand 1+, forkhead box P3+, and cluster of differentiation 68+ cell proportions are also significantly higher in "never-rejection" when compared with "future-rejection." These findings suggest that in situ immune modulators regulate the severity of cardiac allograft rejection.

SUBMITTER: Peyster EG 

PROVIDER: S-EPMC7188920 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7812257 | biostudies-literature
2005-09-01 | GSE2445 | GEO
2005-10-24 | GSE2596 | GEO
2019-08-16 | GSE124897 | GEO
2010-06-10 | E-GEOD-2445 | biostudies-arrayexpress
2021-12-28 | GSE150059 | GEO
2023-01-30 | GSE215240 | GEO
| S-EPMC5976814 | biostudies-other